cbdMD (YCBD) EBIT Growth (3y) (2019 - 2026)
cbdMD (YCBD) EBIT Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 29.31% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 4.24% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 0.90% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1.82% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -74.25% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 27.21% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 35.42% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | 14.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.73% |
| Dec 31, 2025 | 58.64% |
| Sep 30, 2025 | 64.23% |
| Jun 30, 2025 | 69.89% |
| Mar 31, 2025 | 54.06% |
| Dec 31, 2024 | 84.92% |
| Sep 30, 2024 | 64.39% |
| Jun 30, 2024 | 61.46% |
| Mar 31, 2024 | 28.07% |
| Dec 31, 2023 | 15.39% |
| Sep 30, 2023 | -49.75% |
| Jun 30, 2023 | -10.89% |
| Mar 31, 2023 | 37.00% |
| Dec 31, 2022 | 12.85% |
| Sep 30, 2022 | -42.20% |
| Jun 30, 2022 | -72.39% |
| Mar 31, 2022 | -35.20% |
| Dec 31, 2021 | -184.53% |
| Sep 30, 2021 | -36.68% |
| Jun 30, 2021 | -132.96% |